Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Spinal cord cell delivery device tested in 10 patients

NCT ID NCT06841770

First seen Feb 14, 2026 · Last updated May 25, 2026 · Updated 11 times

Summary

This early-stage trial tests a new device that delivers special cells (LCTOPC1) into the spinal cord of people with traumatic spinal cord injury. The goal is to replace or support damaged cells and help improve movement and quality of life. The study includes 10 adults with severe spinal cord injury and focuses on safety and how well the device works.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rancho Research Institue

    NOT_YET_RECRUITING

    Downey, California, 90242, United States

    Contact Email: •••••@•••••

    Contact

  • University of California, San Diego

    RECRUITING

    La Jolla, California, 92037, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.